Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6501
CALL
Beam Therapeutics
BEAM
$2.8B
| $1.27M | ﹤0.01% |
51,300
-41,600
| -45% | -$1.06M |
|
6502
PUT
Pinnacle West Capital
PNW
$12.2B
| $1.27M | ﹤0.01% |
15,000
+7,400
| +97% | +$657K |
|
6503
PUT
Xometry
XMTR
$5.14B
| $1.27M | ﹤0.01% |
29,800
-18,100
| -38% | -$512K |
|
6504
Sprott Uranium Miners ETF
URNM
$2.06B
| $1.27M | ﹤0.01% |
31,526
-50,284
| -61% | -$2.34M |
|
|
GTOS
6505
Invesco Short Duration Total Return Bond ETF
GTOS
$122M
| $1.27M | ﹤0.01% |
51,049
+1,701
| +3% | +$42.5K |
|
6506
H.B. Fuller
FUL
$3.42B
| $1.27M | ﹤0.01% |
18,825
-4,386
| -19% | -$329K |
|
|
OPRA
6507
CALL
Opera Ltd
OPRA
$1.76B
| $1.27M | ﹤0.01% |
67,000
+49,200
| +276% | +$877K |
|
6508
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $1.27M | ﹤0.01% |
20,333
+11,633
| +134% | +$761K |
|
6509
PUT
Elanco Animal Health
ELAN
$11.8B
| $1.27M | ﹤0.01% |
104,500
+23,700
| +29% | +$310K |
|
|
WBA
6510
DELISTED
Walgreens Boots Alliance
WBA
| $1.26M | ﹤0.01% |
135,557
-1,239,906
| -90% | -$11.5M |
|
6511
First Trust China AlphaDEX Fund
FCA
$33.1M
| $1.26M | ﹤0.01% |
+63,075
| New | +$1.29M |
|
6512
CALL
Agilysys
AGYS
$3.14B
| $1.26M | ﹤0.01% |
9,600
-6,800
| -41% | -$833K |
|
6513
CALL
Cardlytics
CDLX
$23.8M
| $1.26M | ﹤0.01% |
34,050
-13,830
| -29% | -$529K |
|
6514
CALL
Acadia Pharmaceuticals
ACAD
$5B
| $1.26M | ﹤0.01% |
68,800
-11,200
| -14% | -$181K |
|
6515
Goldman Sachs MarketBeta Russell 1000 Value Equity ETF
GVUS
$402M
| $1.26M | ﹤0.01% |
+26,542
| New | +$1.31M |
|
|
NEXN
6516
Nexxen International
NEXN
$587M
| $1.26M | ﹤0.01% |
125,895
+36,500
| +41% | +$323K |
|
6517
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$690M
| $1.26M | ﹤0.01% |
18,272
-5,024
| -22% | -$359K |
|
6518
iShares MSCI Qatar ETF
QAT
$62.8M
| $1.26M | ﹤0.01% |
+70,189
| New | +$1.28M |
|
6519
PUT
Federated Hermes
FHI
$4.79B
| $1.26M | ﹤0.01% |
30,600
-19,000
| -38% | -$767K |
|
6520
PUT
Atlanta Braves Holdings Series A
BATRA
$3.68B
| $1.26M | ﹤0.01% |
30,800
+13,200
| +75% | +$555K |
|
6521
PUT
Vera Therapeutics
VERA
$2.28B
| $1.26M | ﹤0.01% |
29,700
+1,800
| +6% | +$79.7K |
|
6522
Rocky Brands
RCKY
$356M
| $1.26M | ﹤0.01% |
55,063
-4,582
| -8% | -$112K |
|
6523
Astec Industries
ASTE
$997M
| $1.25M | ﹤0.01% |
37,351
-26,716
| -42% | -$924K |
|
6524
PUT
Avantis US Small Cap Value ETF
AVUV
$31.7B
| $1.25M | ﹤0.01% |
13,000
+900
| +7% | +$89.4K |
|
6525
PUT
Mirion Technologies
MIR
$3.92B
| $1.25M | ﹤0.01% |
71,900
+21,900
| +44% | +$340K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.